Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > LOCKED & LOADED SET for TAKEOFF

<< Previous

Bullboard Posts

Next >>

Comment by Davesnothereon Jun 28, 2023 1:56pm

493 Views

Post# 35518945

RE:RE:RE:LOCKED & LOADED SET for TAKEOFF

Appreciate your questions, and respect your cynical humour. Appropriate. As fellow share/bag holders we are in the same boat.

That said, think about it, It only makes sense and I have been waiting for it.

The only other reasonable alternative was total final capitulation. There is no more space for downside. No downside risk from where we trade today. Agreed?

So now we wait to see Tetra pull something out of the oven. I hope it will not be disappointing. But history is not on my side.

If it is good news, we will know in less than 4 weeks.

<< Previous

Bullboard Posts

Next >>

TELUS adds 347K customers in Q3